Document Type
Article
Publication Date
8-8-2013
Abstract
The role of heat-stable enterotoxin receptor guanylyl cyclase C (GCC) is well known for its aberrant chloride conductance in the intestinal epithelium in response to bacterial infection. Recently, its use as a molecular marker to detect metastatic colon cancer has grown, as has its use as oral hormone therapy for tumor suppression. This study investigates the preliminary stages of a DNA dendritic cell-based vaccine development specific to targeting guanylyl cyclase in systemic tissues. Construction of the plasmid as well as its transduction to Class I MHC molecules in antigen-presenting dendritic cells is examined. Future exploration includes a comparative assessment of prophylactic and therapeutic treatments.
Recommended Citation
Khurana, MSII, Anmol, "Prophylactic vs. Therapeutic: DNA vaccine to metastatic colorectal cancer using molecular marker guanylyl cyclase-C" (2013). Summer Training Program in Cancer Immunotherapy. Presentation 8.https://jdc.jefferson.edu/summercancerimmunotherapy/8
